ARCHIVES

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

This article is from The Cancer Letter archive.

Vol. 29 No. 41 | November 7, 2003

Download PDF Visit The Full Archive

Related Articles

NCAB Congress to Keep Cigarette Tax At 16 Cents

May 24, 1985

NCI Staff Working Group Leans Toward Starting COP With Community Hospitals As Lead Funding Agencies

January 1, 1982

Senators Urge study section On Clinical Cancer Research

February 4, 1994

NCAB, Hammer Agree On how 41 Billion To Be Handled: No String Attached

October 14, 1988

Markup Completed On Senate Cancer Act Renewal; Waxman Agrees To $90 Million Centers Line Item

May 2, 1980

DeVita Accepts “Chop Lie” Cancer Control Elements In CCOP; RFA Delays Until After May NCAB Meeting

March 12, 1982